Submit Manuscript  

Article Details


Recent Interventions for Nanotechnology Based Drug Products: Insights into the Regulatory Aspects

Author(s):

Amita Sarwal*, Gurpreet Singh, Kirti Singh and Sanjay Garg*   Pages 1 - 10 ( 10 )

Abstract:


Background : Nanotechnology has been one of the most prominent forefront grounds in several traditional research areas of science and technology, and development of medicines at nanoscale can be reflected by the tremendous surge in market interest.

Present outlook: Its applications include various research areas of medicine, drug delivery technology, diagnostic devices, tissue engineering and gene therapy. Along with immense advances, this technology comes with major limitations including potential immune reactivity and complex characterization of these products.

Regulatory challenges: The lack of a proper shaped regulatory perspective due infidelities in scientific findings have led to further uncertainties and vagueness of the nanoscale domain, particularly its safety implications.

Guideline scenario: Early development pathways and regulations should be a top notch priority to help researchers fail faster and more economically. This would facilitate peaking utility of these materials in medicine without compromising public health and environmental integrity. This review attempts to emphasize on regulatory rationales of key considerations in nanotechnology along with a portray of the present scenario.

Recent, Interventions, for, Nanotechnology, Based, Drug, Products:, Insights, into, the, Regulatory, Aspects

Affiliation:

Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, School of Pharmacy and Medical Sciences University of South Australia



Read Full-Text article